Monday, August 31, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· February 10, 2026

Unaudited financial results of LHV Group for Q4 and 12 months of 2025

View original at globenewswire.com
Unaudited financial results of LHV Group for Q4 and 12 months of 2025 At the end of 2025, LHV Group’s deposit and loan portfolio volumes both demonstrated very strong growth…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • LHV Bank in the United Kingdom saw loan portfolio double year-on-year and retail customers reach 5,000 by year-end

    80% confidence
  • LHV Varahaldus delivered the best rate of return in the market and significantly exceeded its financial plan

    80% confidence
  • Full-year profit fell short of the financial plan by 6.5%, but Q4 was strong with nearly 9,000 new customers added in Estonia

    80% confidence
  • LHV Group is confident that capital adequacy as at the end of 2025 has been calculated correctly and in compliance with applicable regulatory requirements

    80% confidence
  • Despite the challenging interest rate environment in the first half of the year, we concluded 2025 with a strong Q4

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI's Trust Gap: Microsoft-Mistral Ecosystem Expansion Meets a Governance Deficit in Agentic Adoption
Microsoft is deepening its AI platform bet through simultaneous moves — expanding its Mistral partnership (Copilot Studio, Foundry, European infrastructure capacity) and deepening enterprise AI governance ties with Manulife — just as independent research (Google Cloud, VentureBeat, Box) shows enterprises racing toward agentic AI adoption (100% planned within two years) while data access and trust in agent decisions lag badly (average 45% data access, only ~half trust agent outputs). The result is a structural mismatch between platform-vendor momentum and enterprise readiness to actually govern and trust the agents being deployed.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
Same entity (Morgan Stanley & Co. LLC), same metric (net_income), same fiscal period (Q1 2026), same observation date (2026-03-31), but vastly different values: $5.567 billion vs. $5.57. These cannot coexist for the same time period. Fact B appears to be a data entry error (possible missing decimal placement: 5.57 should likely be 5,567,000,000 or a per-share figure incorrectly entered as total).
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,257 source documents archived
Query this data → isubstrate.com